Brennan, Paul ![]() |
Official URL: http://dx.doi.org/10.1039/b801920g
Abstract
Transcription factors are a large class of biological molecules that are important for health and disease. Despite that there are challenges to targeting them therapeutically and most approaches alter their activity indirectly. Research at the chemical biology interface has led to the development of new ways of targeting transcription factors including blocking transcription factor dimerisation, targeting specific DNA sequences and DNA decoys. This review discusses these issues with a view to inspiring the development of new agents that could be useful for the treatment of cancer.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine |
Subjects: | R Medicine > RM Therapeutics. Pharmacology |
Publisher: | Royal Society of Chemistry |
ISSN: | 1742-206X |
Last Modified: | 06 May 2023 20:21 |
URI: | https://orca.cardiff.ac.uk/id/eprint/25124 |
Citation Data
Cited 38 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
![]() |
Edit Item |